In Search of Alpha: Asian Hedge Funds in Focus

Asia is in focus for hedge fund managers as it could potentially offer the best alpha per unit of risk taken.

11 Dec 2020

When you look at the alpha per unit of risk that you can capture in a good Asian hedge fund manager, it’s far better than what you’ll see anywhere else

In some of our portfolios, around 40% of our equity allocation is directed toward Asia.

Bruce Amlicke
Chief Investment Officer, UBS Hedge Fund Solutions

Hedge fund investing - the current opportunity set in Asia

“Hedge funds are a relatively new part of the investment landscape in APAC,” says Benno Klingenberg-Timm, Head, Global Sovereign Markets, APAC at UBS Asset Management. “They haven’t been around for as long as they have been in the U.S. or Europe, so there’s not the same history – but you do have very strong performance, and we think the growth of the market will continue to be there, which underlines a continued opportunity set. This is not a short-term perspective. This is really a 10- to 20-year opportunity in Asian hedge fund investing. There will be ups and downs, but there will be a secular shift to this part of the world, and continued growth from Asian investors.”

It’s not hard to argue that Asian equity markets provide an attractive environment for alpha generation. The China A-share market is the second largest equity market in the world and one of the most liquid. Yet it remains hugely inefficient. Approximately 70% of the A-share stocks are covered by fewer than three analysts. This contrasts with the US and Europe where roughly 15% of stocks have such limited analytical coverage (see fig. 1). It is no coincidence that single stock dispersion, a measure of the opportunity for active managers to add value, is nearly double in the Chinese equity market than it is in Europe and the U.S. (see fig. 2).

Figure 1: Coverage of companies with USD 500m market cap

Figure 2: High dispersion of returns in China

Unlike other markets that have seen the level of crowding increase, Asian equity markets currently possess low levels of overall institutional and hedge fund capital that makes the aforementioned inefficiencies more pronounced. In China, the A-share market ownership is dominated by domestic retail investors, with foreign ownership at only 7.3%.1 The dominance of retail investors in Chinese equities and their high portfolio turnover provides plenty of opportunities and liquidity to exploit dislocation. Average annual turnover over the past five years expressed as a percentage of total market capitalization has been significantly higher in the Chinese equity market (266%) than in other developed markets such as the U.S. (126%).2

This is not a short-term perspective. This is really a 10-to 20-year opportunity in Asian hedge fund investing.

Benno Klingenberg-Timm,
Head, Global Sovereign Markets, APAC,
UBS Asset Management Management

Opportunity beyond China

Outside of China, there are potential opportunities arising from corporate governance improvements in Japan and Korea, plus a continuation of high levels of idiosyncratic event activity. Since the introduction of stewardship/corporate governance codes and the new M&A guidelines in Japan, the last two years have seen record numbers of subsidiary sales or transfers and share buybacks.3

The increased amount of private equity capital and activist campaigns in Japan has also resulted in more corporate activity, with a renewed focus on shareholder rights as well as providing a catalyst for value creation.

“We favor Asia, and our allocation mainly consists of equity hedged managers that have shown outsized alpha generation and the ability to manage risk during high levels of volatility,” says Adolfo Oliete, Head of Asia-Pacific Investments, UBS HFS. “In addition, we look for managers who have the ability to perform in volatile or dislocating markets by providing liquidity to the market – for example, multi-strategy managers."

In the near future, pending Qualified Foreign Institutional Investor (QFII) regulation changes, we expect to be able to allocate to some onshore China strategies that have not previously been accessible to offshore capital.

Adolfo Oliete,
Head of Asia-Pacific Investments,
UBS Hedge Fund Solutions

“As we look ahead, the evaluation of risk relative to reward remains paramount,” continues Oliete. “With risk premia compressed across most asset classes, we are focused on identifying idiosyncratic opportunities. Most importantly, we focus on active management in the region. In an Asian hedge fund universe demonstrating high return dispersion, manager selection and exit decisions are paramount to the delivery of investment outcomes.”

In very recent years, we've seen new Asian hedge funds raise as much as $3 billion - that would not have been possible five years ago if you hadn't marketed yourself in the U.S. and Europe. Today, there is … a willingness to put money with them (Asian hedge fund managers).

Ai Ning Wee
Group Chief Investment Officer at Great Eastern Life

Hedge fund investing - taking advantage of the opportunities

The effects of the COVID-19 pandemic have challenged economies around the world, but when 2020 is wrapped up, China will likely prove to be the only large country that has contributed to global GDP growth. It’s no surprise to institutional investors who are enticed by such growth that access to China can be a challenge – especially in the hedge fund space – but it can be decidedly less so when working with an investment partner that knows the lay of the land.

One of the first foreign asset managers to enter China was UBS Asset Management (through a local joint venture), and in the nearly 15 years since doing so it has made China – and Asia overall – a top strategic initiative. As such, investors who work with UBS HFS in a fund of funds context find that the necessary resources have long been in place, and the relationships and knowledge run deep.

We have allocated around $28 billion to Asian hedge funds over the years, so this is not new to us,” says Oliete. “The length of time we’ve been in the region has allowed us to scale our team and solutions to a size appropriate for such a large universe. We have more than 15 people who are dedicated to hedge funds in Asia.

Adolfo Oliette

What really stands out for UBS-AM in the Asian hedge fund space is its onshore presence in China. To launch products in China requires a license, and it is the first foreign player to launch an onshore fund of private funds – funds that are registered in China and offered to Mainland investors.

“The license allows us to have people on the ground, which we do in Shanghai, but also gives us the opportunity to expand the universe of coverage on investments that were previously unavailable to offshore investors due to QFII regulations,” says Oliete. “That is changing, and regulations have expanded what offshore investors can invest in, including Chinese hedge funds that are based in China and registered in China. In that context, we don’t have to catch up on our knowledge of these firms – we’ve been looking at them and getting to know them all along. 

People, presence, and approach

Amlicke, says his group’s work with Asian hedge funds is focused on three things: people, presence, and approach.

“Over the past five years, we’ve ramped up our level of activity and built out our resources even further in the region,” says Amlicke. “Part of what drove it was the U.S equity hedge landscape five years ago. You could really see the increased crowding and a lot of smart cap investors going after the same alpha. It was frustrating, because you’d see periodic factor rotations and de-leveraging events, which would drive correlated losses. Part of really moving more aggressively to Asia was moving away from that and moving toward less crowded opportunities.”

Amlicke and Oliete look to build their team with people who have been direct risk-takers at some point in their career.

Whether they’ve been working for a hedge fund or a prop desk, infusing their experience as direct risk-takers into our decision-making process really fuels our experience in evaluating hedge funds and providing seed funding for a lot of great ones early on,” says Amlicke. “Our deep roots in the region have enabled us to be able to spot talent early and be comfortable with that exposure.

Bruce Amlicke

The approach part of the equation offers investors tremendous flexibility to shape the relationship with UBS HFS. Whether it’s advisory, discretionary or semi- discretionary mandates, APAC-only, emerging managers, or co-investments only, to name a few examples, the pieces can be put together in the way that best suits the asset owners.  

Such flexibility creates a comfort level for investors in what Amlicke describes as the perfect hedge fund market.

“Asia overall has far less hedge fund capital than other markets, and on top of that you have the top-down aspects of powerful secular thematics in China’s efforts to rebalance its big, growing economy and move towards the digital consumer. Along with this secular growth, there’s cyclical growth and huge volatility, so it’s really an opportunity to take advantage of long and short positions.”

Vetting for transparency in Asian hedge funds

Investors are attracted by the alpha potential hedge funds represent, but not as keen on what historically has been a lack of transparency. With Asian hedge funds newer to the scene than their peers in North America and Europe, it’s natural for investors to be curious about how UBS Hedge Fund Solutions selects the funds it invests in – and how those funds are themselves managed.

UBS Hedge Fund Solutions

UBS Hedge Fund Solutions  (HFS) offers a wide range of hedge fund solutions including commingled products and customized discretionary products, as well as portfolio advisory and strategic advisory services. The firm is headquartered in Stamford, Conn., with additional offices in New York, London, Zurich, Hong Kong, San Francisco, Shanghai, Tokyo, and Krakow.

As of 1 October 2020, HFS currently manages approximately USD 35.9 billion and has allocated over USD 275.5 billion since inception. UBS Hedge Fund Solutions (HFS) was founded in 1994 and is a wholly owned subsidiary of UBS Asset Management (Americas) Inc.

HFS is the second largest hedge fund manager globally (Source: HFM InvestHedge Billion Dollar Club, published March 2020).

Subscribe now

Perspectives matter. Tune in to our insights.

Singapore Retail Investors


This website is not intended for and should not be accessed by persons located or resident in any jurisdiction where (by reason of that person's nationality, domicile, residence or otherwise) the publication or availability of this website is prohibited or contrary to local law or regulation or would subject any UBS entity to any registration or licensing requirements in such jurisdictions. It is your responsibility to be aware of, to obtain all relevant regulatory approvals, licenses, verifications and/or registrations under, and to observe all applicable laws and regulations of any relevant jurisdiction in connection with your entrance to this website. Each investment product and service referred to on this website is intended to be made available only to residents in Singapore.

UBS reserves the right to change, modify, add or remove content on the website as well as these terms at any time for any reason without notice. Such changes shall be effective immediately upon posting. You acknowledge that by accessing our website after we have posted changes to these terms, you are agreeing to these terms as modified.

The materials on this Website are distributed by UBS Asset Management (Singapore) Ltd (company registration number: 199308367C), which is licensed by Monetary Authority of Singapore ("MAS") in Singapore pursuant to the Securities and Futures Act (Chapter 289 of Singapore). UBS Asset Management (Singapore) Ltd is part of the Asset Management business division of UBS Group AG. UBS Asset Management (Singapore) Ltd together with UBS Group AG and its group companies shall collectively be referred to as "UBS".

The information contained in this Website has been prepared and is intended for general circulation. The information does not constitute advice and does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The investment services or products referred to in this Website may not be suitable for all investors. UBS recommends that you independently evaluate particular investments and strategies and seek independent advice from a financial adviser regarding the suitability of such investment products, taking into account your specific investment objectives, financial situation and particular needs, before making a commitment to purchase any investment products. Investment involves risks. You should be aware that investments may increase or decrease in value and that past performance is not indicative of future performance.

The information contained in this Website is not an offer to buy or sell or the solicitation of an offer to buy or sell any investment product or to participate in any particular trading strategy. UBS, its officers and/or employees may have interests in any of the investment products referred to on this Website by acting in various roles. UBS, its officers and/or employees may receive fees, commissions or other benefits for acting in those capacities. In addition, UBS, its officers and/or employees may buy or sell investment products as principal or agent and may effect transactions which are not consistent with the information set out in this Website.

You fully understand and agree that, by making available this Website, UBS should not be construed as making: (a) any endorsement of any investment product referred to in this Website; (b) any representation that UBS has performed any due diligence on any investment product referred to in this Website; or (c) any representation that the information in this Website is complete, accurate, clear, fair and not misleading. The use or reliance on any such information contained in this Website is at your own risk and any losses which may be suffered as a result of you entering into any investment are for your account and UBS shall not be liable for any losses arising from or incurred by you in connection therewith. UBS is not responsible or liable for the accuracy and completeness of any such information or the performance or outcome of any investment made by you after receipt of such information, irrespective of whether such information was provided at your request.

Using, copying, redistributing or republishing any part of this Website without prior written permission from UBS is prohibited. Any statements made regarding investment performance objectives, risk and/or return targets shall not constitute a representation or warranty that such objectives or expectations will be achieved or risks are fully disclosed. The information and opinions contained in this Website is based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any misrepresentation, errors or omissions. All such information and opinions are subject to change without notice. A number of comments in this Website are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a reflection of UBS’s judgment at the time this document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.

UBS does not hold out any of its officers and/or employees as having any authority to advise you, and UBS does not purport to advise you on any investment product. Any investment will be made at your sole risk and UBS is not and shall not, in any manner, be liable or responsible for the consequences of any investment.

This Website and its contents are provided on an “as is” and “as available” basis. UBS does not warrant: (a) the accuracy, timeliness, adequacy commercial value or completeness of this Website or its contents, and expressly disclaims any liability for errors, delays or omissions in the contents, or for any action taken in reliance on the contents; (b) that your use of and/or access to this Website or its contents, will be uninterrupted, timely, secure or free from errors or that any identified defect will be corrected; (c) that this Website or any content will meet your requirements or are free from any virus or other malicious, destructive or corrupting code, agent, program or macros; (d) that any information, instructions or communications posted or transmitted by you through this Website is secure and cannot be accessed by unauthorised third parties; and (e) that use of the contents in this Website by you will not infringe the rights of any third parties. No warranty of any kind, implied, express or statutory, including but not limited to the warranties of non-infringement of third party rights, title, merchantability, satisfactory quality or fitness for a particular purpose and freedom from computer virus or other malicious, destructive or corrupting code, agent, program or macros, is given in conjunction with this Website.

You hereby agree to indemnify UBS and any of its officers, employees or agents against, and to keep UBS and any of its officers, employees or agents harmless from, any claims (actual and threatened), settlement sums, liability, loss, damages, costs (including solicitor and client costs and expenses (legal or otherwise)), charges, expenses, actions, proceedings, whether foreseeable or not which we may sustain, suffer or incur, directly or indirectly out of or in the course of or in connection with any the following: (a) any use of this Website or the contents by you, or any part thereof; (b) UBS having made available the Website; (c) any breach of these Terms by you, however arising; or (d) any negligence, act or omission, wilful default, unlawful act, fraud and/or misconduct on your part or violation of any rights of another person or entity by you.

The funds referred to in this Website have been authorised or recognised by the MAS for sale to the public in Singapore (the “Funds”). Copies of the registered Singapore prospectuses ("Prospectuses") referred to in this Website have been lodged with and registered by the MAS. The MAS assumes no responsibility for the contents of the Prospectuses. The registration of the Prospectuses by the MAS does not imply that the SFA or any other legal or regulatory requirements have been complied with.

MAS registration is not a recommendation or endorsement of a Fund nor does it guarantee the commercial merits or performance of such Fund. It does not mean that a Fund is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. UBS Asset Management (Singapore) Ltd has been appointed as the representative for the Funds in Singapore for the purposes of performing administrative and other related functions relating to the offer of Shares under Section 287 of the Securities and Futures Act, Chapter 289 of Singapore (the "SFA") and such other functions as the MAS may prescribe.

You may not assign your rights under the Terms without our prior written consent. UBS Asset Management (Singapore) Ltd may assign our rights under the Terms to any third party.

No person or entity who is not a party to the Terms shall have any right under the Contracts (Rights of Third Parties) Act, Chapter 53B of Singapore or other similar laws to enforce any term of the Terms regardless of whether such person or entity has been identified by name, as a member of a class or as answering a particular description. For the avoidance of doubt, this shall not affect the rights of any permitted assignee or transferee of the Terms.

These Terms shall be governed by, and shall be construed in accordance with, the laws of Singapore. The courts of Singapore shall have exclusive jurisdiction to hear and determine any suit, action or proceeding, and to settle any disputes, which may arise out of or in connection with these Terms and, for such purposes, you agree to submit  to the jurisdiction of the courts of Singapore. Each party hereby waives any objection which it might at any time have to the courts of Singapore being nominated as the forum to hear and determine any proceedings and to settle any disputes and agrees not to claim that the courts of Singapore are not a convenient or appropriate forum.

© UBS 2021 - the key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.


More insights